This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
JCR Pharmaceuticals Co., Ltd.
Drug Names(s): darbepoetin alfa, JR131
Description: JR-131 is a biosimilar for a long-acting erythropoiesis-stimulating agent, darbeopoetin alfa.
JCR and Kissei
In 2013, JCR entered into a joint development agreement with Kissei Pharmaceutical Co.,Ltd. for follow-on biologics of long-acting erythropoiesis stimulating agent (darbopoietin alfa).
Partners: Kissei Pharmaceutical Co., Ltd
Additional information available to subscribers only: